Pleuropulmonary and Bronchial Infections
- Low Immunity Against COVID-19 Omicron Variants Despite 3 Vaccine Doses in Hematologic Malignancies
- Risk Factors for Late-Onset P jirovecii Pneumonia After Liver Transplantation
- FDA Approves Xacduro for Difficult-to-Treat Bacterial Pneumonia
- COVID-19 Hospitalizations Reach Record Low in United States
- Use of Mesenchymal Stromal Cells Is Safe But Not Effective in COVID-19 ARDS
- Paxlovid Receives FDA Approval for COVID-19 Treatment
- Primary COVID-19 Infection Plus Vaccination Significantly Protects Against Reinfection
- Low Risk of Recurrent Thrombotic Events After COVID-19-Linked VTE
- Nirsevimab Safe for Infants With RSV, Significantly Reduces Hospitalization Incidence
- Xacduro Gets FDA Approval for Pneumonia Caused by Acinetobacter baumannii
- Cardiovascular Complications of COVID-19 Increased Throughout the Pandemic
- Physical Activity Affects Influenza, Pneumonia Mortality
Clinical Tools
Powered by
Powered by 
